Linked Life Data

2671418

Source:http://linkedlifedata.com/resource/pubmed/id/2671418

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1989-10-6
pubmed:abstractText
Early medical intervention in human immunodeficiency virus disease has far-reaching implications for the health care system of the United States. Several factors are enabling the medical community to begin intervention prior to a patient's diagnosis of acquired immunodeficiency syndrome. These factors include an understanding of the biologic markers of disease progression; advances in antiviral therapeutics; and an improved ability to control the most common presenting opportunistic infection, Pneumocystis carinii pneumonia. Providing adequate ambulatory care for large numbers of asymptomatic human immunodeficiency virus-infected individuals and coordinating inner-city health care facilities will become critical. Important questions regarding service provision need to be adequately addressed. The cost of yearly treatment, estimated to be $5 billion per year, will require a major financial commitment at all levels of government and the private sector. Effective early intervention in human immunodeficiency virus disease may alter the course of one of the most devastating epidemics in modern history. Planning for its implementation should begin immediately.
pubmed:grant
pubmed:commentsCorrections
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0098-7484
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
262
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1493-8
pubmed:dateRevised
2007-11-14
pubmed:otherAbstract
KIE: The promise of early intervention in the course of human immunodeficiency virus (HIV) disease to slow or prevent its progression to AIDS has far-reaching implications for health care in the United States. Medical advances could bring tens of thousands of asymptomatic seropositive individuals into the health care system. The demand for HIV testing, counseling, laboratory monitoring, medications, and overall primary health care will be great, particularly among previously underserved groups such as intravenous drug users and the urban poor. Treatment of HIV positive patients could cost as much as $5 billion per year, and would require a major financial commitment from all levels of government as well as from the private sector. The authors call for rational planning for early intervention in HIV disease to avoid the crisis-driven policy making that has characterized the AIDS epidemic until now.
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Economic and policy implications of early intervention in HIV disease.
pubmed:affiliation
Department of Epidemiology and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't